✉ Email this page to a colleague
« Back to Dashboard
Methylin is a drug marketed by Specgx Llc and is included in three NDAs. There is one patent protecting this drug and one Paragraph IV challenge.
This drug has ten patent family members in nine countries.
The generic ingredient in METHYLIN is methylphenidate hydrochloride. There are thirty-two drug master file entries for this compound. Forty-four suppliers are listed for this compound. Additional details are available on the methylphenidate hydrochloride profile page.
A generic version of METHYLIN was approved as methylphenidate hydrochloride by SPECGX LLC on November 27th, 1998.
Summary for METHYLIN
|Finished Product Suppliers / Packagers:||1|
|Raw Ingredient (Bulk) Api Vendors:||22|
|Formulation / Manufacturing:||see details|
|Drug Prices:||Drug price information for METHYLIN|
|Patent Litigation and PTAB cases:||See patent lawsuits and PTAB cases for METHYLIN|
|What excipients (inactive ingredients) are in METHYLIN?||METHYLIN excipients list|
|DailyMed Link:||METHYLIN at DailyMed|
Recent Clinical Trials for METHYLIN
Identify potential brand extensions & 505(b)(2) entrants
|Nicoleta Stoicea||Phase 1|
|Boston Children's Hospital||Phase 1|
|Dana-Farber Cancer Institute||Phase 1|
See the table below for patents covering METHYLIN around the world.
|Country||Patent Number||Title||Estimated Expiration|
|Canada||2540052||SOLUTION DE METHYLPHENIDATE ET PROCEDES ASSOCIES D'ADMINISTRATION ET DE PRODUCTION (METHYLPHENIDATE SOLUTION AND ASSOCIATED METHODS OF ADMINISTRATION AND PRODUCTION)||See Plans and Pricing|
|Japan||2007508313||See Plans and Pricing|
|Japan||4959335||See Plans and Pricing|
|Spain||2373042||See Plans and Pricing|
|Austria||526988||See Plans and Pricing|
|World Intellectual Property Organization (WIPO)||2005035000||See Plans and Pricing|
|China||1867359||Methylphenidate solution and associated methods of administration and produciton||See Plans and Pricing|
|>Country||>Patent Number||>Title||>Estimated Expiration|